カテゴリー： Market Monitor Global, 世界, 医療/バイオ

経口ワクチンアジュバントの世界市場見通し2023年-2029年

◆英語タイトル：Oral Vaccine Adjuvants Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5441）

◆商品コード：MMG23JU5441
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：115
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Oral Vaccine Adjuvants Market 調査レポートは次の情報を含め、グローバルにおけるの経口ワクチンアジュバント市場規模と予測を収録しています。・世界の経口ワクチンアジュバント市場：売上、2018年-2023年、2024年-2029年
・世界の経口ワクチンアジュバント市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経口ワクチンアジュバント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「動物用ワクチンアジュバント」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

経口ワクチンアジュバントのグローバル主要企業は、SEPPIC、 SDA BIO、 Croda International、 SPI Pharma、 Phibro Animal Health Corporation、 Tj Kaiwei、 Novavax、 Zhuoyue、 Aphios、 GSK、 CSL、 Brenntag Biosector、 SEPPIC、 SPI Pharma、 Novavax、 Avanti Polar Lipids、 Aphiosなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、経口ワクチンアジュバントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の経口ワクチンアジュバント市場：タイプ別、2018年-2023年、2024年-2029年
世界の経口ワクチンアジュバント市場：タイプ別市場シェア、2022年
・動物用ワクチンアジュバント、人間用ワクチンアジュバント

世界の経口ワクチンアジュバント市場：用途別、2018年-2023年、2024年-2029年
世界の経口ワクチンアジュバント市場：用途別市場シェア、2022年
・研究用、商業用

世界の経口ワクチンアジュバント市場：地域・国別、2018年-2023年、2024年-2029年
世界の経口ワクチンアジュバント市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における経口ワクチンアジュバントのグローバル売上、2018年-2023年
・主要企業における経口ワクチンアジュバントのグローバル売上シェア、2022年
・主要企業における経口ワクチンアジュバントのグローバル販売量、2018年-2023年
・主要企業における経口ワクチンアジュバントのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
SEPPIC、 SDA BIO、 Croda International、 SPI Pharma、 Phibro Animal Health Corporation、 Tj Kaiwei、 Novavax、 Zhuoyue、 Aphios、 GSK、 CSL、 Brenntag Biosector、 SEPPIC、 SPI Pharma、 Novavax、 Avanti Polar Lipids、 Aphios

*************************************************************

・調査・分析レポートの概要
経口ワクチンアジュバント市場の定義
市場セグメント
世界の経口ワクチンアジュバント市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経口ワクチンアジュバント市場規模
世界の経口ワクチンアジュバント市場規模：2022年 VS 2029年
世界の経口ワクチンアジュバント市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経口ワクチンアジュバントの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経口ワクチンアジュバント製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：動物用ワクチンアジュバント、人間用ワクチンアジュバント
経口ワクチンアジュバントのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：研究用、商業用
経口ワクチンアジュバントの用途別グローバル売上・予測

・地域別市場分析
地域別経口ワクチンアジュバント市場規模 2022年と2029年
地域別経口ワクチンアジュバント売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
SEPPIC、 SDA BIO、 Croda International、 SPI Pharma、 Phibro Animal Health Corporation、 Tj Kaiwei、 Novavax、 Zhuoyue、 Aphios、 GSK、 CSL、 Brenntag Biosector、 SEPPIC、 SPI Pharma、 Novavax、 Avanti Polar Lipids、 Aphios
...

Vaccine adjuvants (Adjuvant) are a class of substances that can non-specifically change or enhance the body’s specific immune response to antigens and play an auxiliary role. Adjuvants can induce the body to produce a long-term and efficient specific immune response, improve the body’s protective ability, and at the same time reduce the dosage of immune substances and reduce the production cost of vaccines.
This report aims to provide a comprehensive presentation of the global market for Oral Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccine Adjuvants. This report contains market size and forecasts of Oral Vaccine Adjuvants in global, including the following market information:
Global Oral Vaccine Adjuvants Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oral Vaccine Adjuvants Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Oral Vaccine Adjuvants companies in 2022 (%)
The global Oral Vaccine Adjuvants market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Veterinary Vaccine Adjuvants Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Vaccine Adjuvants include SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Vaccine Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Vaccine Adjuvants Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Vaccine Adjuvants Market Segment Percentages, by Type, 2022 (%)
Veterinary Vaccine Adjuvants
Human Vaccine Adjuvants
Global Oral Vaccine Adjuvants Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Vaccine Adjuvants Market Segment Percentages, by Application, 2022 (%)
Research Application
Commercial Application
Global Oral Vaccine Adjuvants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Vaccine Adjuvants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Vaccine Adjuvants revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oral Vaccine Adjuvants revenues share in global market, 2022 (%)
Key companies Oral Vaccine Adjuvants sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oral Vaccine Adjuvants sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Vaccine Adjuvants, market overview.
Chapter 2: Global Oral Vaccine Adjuvants market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Vaccine Adjuvants capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oral Vaccine Adjuvants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Vaccine Adjuvants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Vaccine Adjuvants Overall Market Size
2.1 Global Oral Vaccine Adjuvants Market Size: 2022 VS 2029
2.2 Global Oral Vaccine Adjuvants Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oral Vaccine Adjuvants Sales: 2018-2029
3 Company Landscape
3.1 Top Oral Vaccine Adjuvants Players in Global Market
3.2 Top Global Oral Vaccine Adjuvants Companies Ranked by Revenue
3.3 Global Oral Vaccine Adjuvants Revenue by Companies
3.4 Global Oral Vaccine Adjuvants Sales by Companies
3.5 Global Oral Vaccine Adjuvants Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral Vaccine Adjuvants Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral Vaccine Adjuvants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Vaccine Adjuvants Players in Global Market
3.8.1 List of Global Tier 1 Oral Vaccine Adjuvants Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Vaccine Adjuvants Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oral Vaccine Adjuvants Market Size Markets, 2022 & 2029
4.1.2 Veterinary Vaccine Adjuvants
4.1.3 Human Vaccine Adjuvants
4.2 By Type – Global Oral Vaccine Adjuvants Revenue & Forecasts
4.2.1 By Type – Global Oral Vaccine Adjuvants Revenue, 2018-2023
4.2.2 By Type – Global Oral Vaccine Adjuvants Revenue, 2024-2029
4.2.3 By Type – Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
4.3 By Type – Global Oral Vaccine Adjuvants Sales & Forecasts
4.3.1 By Type – Global Oral Vaccine Adjuvants Sales, 2018-2023
4.3.2 By Type – Global Oral Vaccine Adjuvants Sales, 2024-2029
4.3.3 By Type – Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
4.4 By Type – Global Oral Vaccine Adjuvants Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oral Vaccine Adjuvants Market Size, 2022 & 2029
5.1.2 Research Application
5.1.3 Commercial Application
5.2 By Application – Global Oral Vaccine Adjuvants Revenue & Forecasts
5.2.1 By Application – Global Oral Vaccine Adjuvants Revenue, 2018-2023
5.2.2 By Application – Global Oral Vaccine Adjuvants Revenue, 2024-2029
5.2.3 By Application – Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
5.3 By Application – Global Oral Vaccine Adjuvants Sales & Forecasts
5.3.1 By Application – Global Oral Vaccine Adjuvants Sales, 2018-2023
5.3.2 By Application – Global Oral Vaccine Adjuvants Sales, 2024-2029
5.3.3 By Application – Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
5.4 By Application – Global Oral Vaccine Adjuvants Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oral Vaccine Adjuvants Market Size, 2022 & 2029
6.2 By Region – Global Oral Vaccine Adjuvants Revenue & Forecasts
6.2.1 By Region – Global Oral Vaccine Adjuvants Revenue, 2018-2023
6.2.2 By Region – Global Oral Vaccine Adjuvants Revenue, 2024-2029
6.2.3 By Region – Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
6.3 By Region – Global Oral Vaccine Adjuvants Sales & Forecasts
6.3.1 By Region – Global Oral Vaccine Adjuvants Sales, 2018-2023
6.3.2 By Region – Global Oral Vaccine Adjuvants Sales, 2024-2029
6.3.3 By Region – Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oral Vaccine Adjuvants Revenue, 2018-2029
6.4.2 By Country – North America Oral Vaccine Adjuvants Sales, 2018-2029
6.4.3 US Oral Vaccine Adjuvants Market Size, 2018-2029
6.4.4 Canada Oral Vaccine Adjuvants Market Size, 2018-2029
6.4.5 Mexico Oral Vaccine Adjuvants Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oral Vaccine Adjuvants Revenue, 2018-2029
6.5.2 By Country – Europe Oral Vaccine Adjuvants Sales, 2018-2029
6.5.3 Germany Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.4 France Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.5 U.K. Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.6 Italy Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.7 Russia Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.8 Nordic Countries Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.9 Benelux Oral Vaccine Adjuvants Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oral Vaccine Adjuvants Revenue, 2018-2029
6.6.2 By Region – Asia Oral Vaccine Adjuvants Sales, 2018-2029
6.6.3 China Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.4 Japan Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.5 South Korea Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.6 Southeast Asia Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.7 India Oral Vaccine Adjuvants Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oral Vaccine Adjuvants Revenue, 2018-2029
6.7.2 By Country – South America Oral Vaccine Adjuvants Sales, 2018-2029
6.7.3 Brazil Oral Vaccine Adjuvants Market Size, 2018-2029
6.7.4 Argentina Oral Vaccine Adjuvants Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oral Vaccine Adjuvants Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oral Vaccine Adjuvants Sales, 2018-2029
6.8.3 Turkey Oral Vaccine Adjuvants Market Size, 2018-2029
6.8.4 Israel Oral Vaccine Adjuvants Market Size, 2018-2029
6.8.5 Saudi Arabia Oral Vaccine Adjuvants Market Size, 2018-2029
6.8.6 UAE Oral Vaccine Adjuvants Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 SEPPIC
7.1.1 SEPPIC Company Summary
7.1.2 SEPPIC Business Overview
7.1.3 SEPPIC Oral Vaccine Adjuvants Major Product Offerings
7.1.4 SEPPIC Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.1.5 SEPPIC Key News & Latest Developments
7.2 SDA BIO
7.2.1 SDA BIO Company Summary
7.2.2 SDA BIO Business Overview
7.2.3 SDA BIO Oral Vaccine Adjuvants Major Product Offerings
7.2.4 SDA BIO Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.2.5 SDA BIO Key News & Latest Developments
7.3 Croda International
7.3.1 Croda International Company Summary
7.3.2 Croda International Business Overview
7.3.3 Croda International Oral Vaccine Adjuvants Major Product Offerings
7.3.4 Croda International Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.3.5 Croda International Key News & Latest Developments
7.4 SPI Pharma
7.4.1 SPI Pharma Company Summary
7.4.2 SPI Pharma Business Overview
7.4.3 SPI Pharma Oral Vaccine Adjuvants Major Product Offerings
7.4.4 SPI Pharma Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.4.5 SPI Pharma Key News & Latest Developments
7.5 Phibro Animal Health Corporation
7.5.1 Phibro Animal Health Corporation Company Summary
7.5.2 Phibro Animal Health Corporation Business Overview
7.5.3 Phibro Animal Health Corporation Oral Vaccine Adjuvants Major Product Offerings
7.5.4 Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.5.5 Phibro Animal Health Corporation Key News & Latest Developments
7.6 Tj Kaiwei
7.6.1 Tj Kaiwei Company Summary
7.6.2 Tj Kaiwei Business Overview
7.6.3 Tj Kaiwei Oral Vaccine Adjuvants Major Product Offerings
7.6.4 Tj Kaiwei Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.6.5 Tj Kaiwei Key News & Latest Developments
7.7 Novavax
7.7.1 Novavax Company Summary
7.7.2 Novavax Business Overview
7.7.3 Novavax Oral Vaccine Adjuvants Major Product Offerings
7.7.4 Novavax Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.7.5 Novavax Key News & Latest Developments
7.8 Zhuoyue
7.8.1 Zhuoyue Company Summary
7.8.2 Zhuoyue Business Overview
7.8.3 Zhuoyue Oral Vaccine Adjuvants Major Product Offerings
7.8.4 Zhuoyue Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.8.5 Zhuoyue Key News & Latest Developments
7.9 Aphios
7.9.1 Aphios Company Summary
7.9.2 Aphios Business Overview
7.9.3 Aphios Oral Vaccine Adjuvants Major Product Offerings
7.9.4 Aphios Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.9.5 Aphios Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Oral Vaccine Adjuvants Major Product Offerings
7.10.4 GSK Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 CSL
7.11.1 CSL Company Summary
7.11.2 CSL Oral Vaccine Adjuvants Business Overview
7.11.3 CSL Oral Vaccine Adjuvants Major Product Offerings
7.11.4 CSL Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.11.5 CSL Key News & Latest Developments
7.12 Brenntag Biosector
7.12.1 Brenntag Biosector Company Summary
7.12.2 Brenntag Biosector Oral Vaccine Adjuvants Business Overview
7.12.3 Brenntag Biosector Oral Vaccine Adjuvants Major Product Offerings
7.12.4 Brenntag Biosector Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.12.5 Brenntag Biosector Key News & Latest Developments
7.13 SEPPIC
7.13.1 SEPPIC Company Summary
7.13.2 SEPPIC Oral Vaccine Adjuvants Business Overview
7.13.3 SEPPIC Oral Vaccine Adjuvants Major Product Offerings
7.13.4 SEPPIC Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.13.5 SEPPIC Key News & Latest Developments
7.14 SPI Pharma
7.14.1 SPI Pharma Company Summary
7.14.2 SPI Pharma Business Overview
7.14.3 SPI Pharma Oral Vaccine Adjuvants Major Product Offerings
7.14.4 SPI Pharma Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.14.5 SPI Pharma Key News & Latest Developments
7.15 Novavax
7.15.1 Novavax Company Summary
7.15.2 Novavax Business Overview
7.15.3 Novavax Oral Vaccine Adjuvants Major Product Offerings
7.15.4 Novavax Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.15.5 Novavax Key News & Latest Developments
7.16 Avanti Polar Lipids
7.16.1 Avanti Polar Lipids Company Summary
7.16.2 Avanti Polar Lipids Business Overview
7.16.3 Avanti Polar Lipids Oral Vaccine Adjuvants Major Product Offerings
7.16.4 Avanti Polar Lipids Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.16.5 Avanti Polar Lipids Key News & Latest Developments
7.17 Aphios
7.17.1 Aphios Company Summary
7.17.2 Aphios Business Overview
7.17.3 Aphios Oral Vaccine Adjuvants Major Product Offerings
7.17.4 Aphios Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.17.5 Aphios Key News & Latest Developments
8 Global Oral Vaccine Adjuvants Production Capacity, Analysis
8.1 Global Oral Vaccine Adjuvants Production Capacity, 2018-2029
8.2 Oral Vaccine Adjuvants Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Vaccine Adjuvants Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Vaccine Adjuvants Supply Chain Analysis
10.1 Oral Vaccine Adjuvants Industry Value Chain
10.2 Oral Vaccine Adjuvants Upstream Market
10.3 Oral Vaccine Adjuvants Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Vaccine Adjuvants Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oral Vaccine Adjuvants in Global Market
Table 2. Top Oral Vaccine Adjuvants Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oral Vaccine Adjuvants Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oral Vaccine Adjuvants Revenue Share by Companies, 2018-2023
Table 5. Global Oral Vaccine Adjuvants Sales by Companies, (K Units), 2018-2023
Table 6. Global Oral Vaccine Adjuvants Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oral Vaccine Adjuvants Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Oral Vaccine Adjuvants Product Type
Table 9. List of Global Tier 1 Oral Vaccine Adjuvants Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Vaccine Adjuvants Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oral Vaccine Adjuvants Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Oral Vaccine Adjuvants Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oral Vaccine Adjuvants Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Oral Vaccine Adjuvants Sales (K Units), 2018-2023
Table 15. By Type - Global Oral Vaccine Adjuvants Sales (K Units), 2024-2029
Table 16. By Application – Global Oral Vaccine Adjuvants Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Oral Vaccine Adjuvants Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oral Vaccine Adjuvants Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Oral Vaccine Adjuvants Sales (K Units), 2018-2023
Table 20. By Application - Global Oral Vaccine Adjuvants Sales (K Units), 2024-2029
Table 21. By Region – Global Oral Vaccine Adjuvants Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Oral Vaccine Adjuvants Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oral Vaccine Adjuvants Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Oral Vaccine Adjuvants Sales (K Units), 2018-2023
Table 25. By Region - Global Oral Vaccine Adjuvants Sales (K Units), 2024-2029
Table 26. By Country - North America Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oral Vaccine Adjuvants Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Oral Vaccine Adjuvants Sales, (K Units), 2018-2023
Table 29. By Country - North America Oral Vaccine Adjuvants Sales, (K Units), 2024-2029
Table 30. By Country - Europe Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oral Vaccine Adjuvants Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Oral Vaccine Adjuvants Sales, (K Units), 2018-2023
Table 33. By Country - Europe Oral Vaccine Adjuvants Sales, (K Units), 2024-2029
Table 34. By Region - Asia Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oral Vaccine Adjuvants Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Oral Vaccine Adjuvants Sales, (K Units), 2018-2023
Table 37. By Region - Asia Oral Vaccine Adjuvants Sales, (K Units), 2024-2029
Table 38. By Country - South America Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oral Vaccine Adjuvants Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Oral Vaccine Adjuvants Sales, (K Units), 2018-2023
Table 41. By Country - South America Oral Vaccine Adjuvants Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oral Vaccine Adjuvants Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Oral Vaccine Adjuvants Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Oral Vaccine Adjuvants Sales, (K Units), 2024-2029
Table 46. SEPPIC Company Summary
Table 47. SEPPIC Oral Vaccine Adjuvants Product Offerings
Table 48. SEPPIC Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. SEPPIC Key News & Latest Developments
Table 50. SDA BIO Company Summary
Table 51. SDA BIO Oral Vaccine Adjuvants Product Offerings
Table 52. SDA BIO Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. SDA BIO Key News & Latest Developments
Table 54. Croda International Company Summary
Table 55. Croda International Oral Vaccine Adjuvants Product Offerings
Table 56. Croda International Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Croda International Key News & Latest Developments
Table 58. SPI Pharma Company Summary
Table 59. SPI Pharma Oral Vaccine Adjuvants Product Offerings
Table 60. SPI Pharma Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. SPI Pharma Key News & Latest Developments
Table 62. Phibro Animal Health Corporation Company Summary
Table 63. Phibro Animal Health Corporation Oral Vaccine Adjuvants Product Offerings
Table 64. Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Phibro Animal Health Corporation Key News & Latest Developments
Table 66. Tj Kaiwei Company Summary
Table 67. Tj Kaiwei Oral Vaccine Adjuvants Product Offerings
Table 68. Tj Kaiwei Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Tj Kaiwei Key News & Latest Developments
Table 70. Novavax Company Summary
Table 71. Novavax Oral Vaccine Adjuvants Product Offerings
Table 72. Novavax Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Novavax Key News & Latest Developments
Table 74. Zhuoyue Company Summary
Table 75. Zhuoyue Oral Vaccine Adjuvants Product Offerings
Table 76. Zhuoyue Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Zhuoyue Key News & Latest Developments
Table 78. Aphios Company Summary
Table 79. Aphios Oral Vaccine Adjuvants Product Offerings
Table 80. Aphios Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Aphios Key News & Latest Developments
Table 82. GSK Company Summary
Table 83. GSK Oral Vaccine Adjuvants Product Offerings
Table 84. GSK Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. GSK Key News & Latest Developments
Table 86. CSL Company Summary
Table 87. CSL Oral Vaccine Adjuvants Product Offerings
Table 88. CSL Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. CSL Key News & Latest Developments
Table 90. Brenntag Biosector Company Summary
Table 91. Brenntag Biosector Oral Vaccine Adjuvants Product Offerings
Table 92. Brenntag Biosector Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Brenntag Biosector Key News & Latest Developments
Table 94. SEPPIC Company Summary
Table 95. SEPPIC Oral Vaccine Adjuvants Product Offerings
Table 96. SEPPIC Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. SEPPIC Key News & Latest Developments
Table 98. SPI Pharma Company Summary
Table 99. SPI Pharma Oral Vaccine Adjuvants Product Offerings
Table 100. SPI Pharma Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. SPI Pharma Key News & Latest Developments
Table 102. Novavax Company Summary
Table 103. Novavax Oral Vaccine Adjuvants Product Offerings
Table 104. Novavax Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Novavax Key News & Latest Developments
Table 106. Avanti Polar Lipids Company Summary
Table 107. Avanti Polar Lipids Oral Vaccine Adjuvants Product Offerings
Table 108. Avanti Polar Lipids Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Avanti Polar Lipids Key News & Latest Developments
Table 110. Aphios Company Summary
Table 111. Aphios Oral Vaccine Adjuvants Product Offerings
Table 112. Aphios Oral Vaccine Adjuvants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Aphios Key News & Latest Developments
Table 114. Oral Vaccine Adjuvants Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 115. Global Oral Vaccine Adjuvants Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Oral Vaccine Adjuvants Production by Region, 2018-2023 (K Units)
Table 117. Global Oral Vaccine Adjuvants Production by Region, 2024-2029 (K Units)
Table 118. Oral Vaccine Adjuvants Market Opportunities & Trends in Global Market
Table 119. Oral Vaccine Adjuvants Market Drivers in Global Market
Table 120. Oral Vaccine Adjuvants Market Restraints in Global Market
Table 121. Oral Vaccine Adjuvants Raw Materials
Table 122. Oral Vaccine Adjuvants Raw Materials Suppliers in Global Market
Table 123. Typical Oral Vaccine Adjuvants Downstream
Table 124. Oral Vaccine Adjuvants Downstream Clients in Global Market
Table 125. Oral Vaccine Adjuvants Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Vaccine Adjuvants Segment by Type in 2022
Figure 2. Oral Vaccine Adjuvants Segment by Application in 2022
Figure 3. Global Oral Vaccine Adjuvants Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Vaccine Adjuvants Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oral Vaccine Adjuvants Revenue, 2018-2029 (US$, Mn)
Figure 7. Oral Vaccine Adjuvants Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral Vaccine Adjuvants Revenue in 2022
Figure 9. By Type - Global Oral Vaccine Adjuvants Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 11. By Type - Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 12. By Type - Global Oral Vaccine Adjuvants Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Oral Vaccine Adjuvants Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 15. By Application - Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 16. By Application - Global Oral Vaccine Adjuvants Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Oral Vaccine Adjuvants Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Oral Vaccine Adjuvants Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 20. By Region - Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 21. By Country - North America Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 22. By Country - North America Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 23. US Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 28. Germany Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 29. France Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 37. China Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 41. India Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 43. By Country - South America Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 44. Brazil Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Oral Vaccine Adjuvants Sales Market Share, 2018-2029
Figure 48. Turkey Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Oral Vaccine Adjuvants Revenue, (US$, Mn), 2018-2029
Figure 52. Global Oral Vaccine Adjuvants Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Oral Vaccine Adjuvants by Region, 2022 VS 2029
Figure 54. Oral Vaccine Adjuvants Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経口ワクチンアジュバントの世界市場見通し2023年-2029年(Oral Vaccine Adjuvants Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

経口ワクチンアジュバントの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp